VIARES granted IAOCR 5-Star accreditation for its CRA training program
VIARES’ training program was developed to train entry-level CRAs – a vital role in the clinical research industry for which there has been a significant shortage.
VIARES’ training program was developed to train entry-level CRAs – a vital role in the clinical research industry for which there has been a significant shortage.
CSL has announced that its full year results saw the company’s net profit increase by 30%, in the same year that it announced plans for a 1.8m-square-foot expansion to its Illinois site.
Alnylam received US FDA approval for its first-in-class RNAi treatment, Onpattro, but a spokesperson confirmed manufacturing for the treatment is a complicated affair.
Fueled by increasing investments from biotech, Charles River expects to double the size of its business over the next five years – organically and through M&A – to become a ‘more responsive partner,’ says CEO.
Tjoapack launched a postponement packaging service to address supply chain challenges.
Trans-Hit Bio, a worldwide CRO, has signed a commercial agreement with the biobank of Arizona’s Maricopa Integrated Health System.
Evotec is conducting preclinical and toxicology/safety studies for Stealth BioTherapeutics’ lead candidate, ahead of clinical trials slated to begin in 2019.